Doylestown, PA, United States of America

Daria Hazuda

USPTO Granted Patents = 8 



Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2001-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Daria Hazuda: Innovator in HIV Treatment

Introduction

Daria Hazuda is a prominent inventor based in Doylestown, PA (US), known for her significant contributions to the field of HIV treatment. With a total of eight patents to her name, she has made remarkable strides in developing methods to combat HIV and AIDS.

Latest Patents

Among her latest patents is a method for the treatment and prophylaxis of HIV and AIDS. This invention focuses on inhibiting HIV reverse transcriptase and aims to provide effective treatment for individuals infected with HIV. It also addresses the prophylaxis of HIV infection and the management of AIDS or ARC through the administration of specific compounds. Another notable patent involves a drug combination designed to increase the barrier against resistance to antiviral treatments. This method reduces the risk of developing treatment resistance due to HIV mutations by administering EFdA alongside other antiviral agents.

Career Highlights

Daria has worked with leading pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. Her work in these organizations has allowed her to contribute to groundbreaking research and development in the field of HIV treatment.

Collaborations

Throughout her career, Daria has collaborated with esteemed colleagues such as Michael D. Miller and Jay A. Grobler. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Daria Hazuda's work in HIV treatment exemplifies her dedication to advancing medical science and improving patient outcomes. Her innovative patents and collaborations highlight her significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…